HIGHLIGHTS
- who: April and colleagues from the Virginia Commonwealth UniversityUnited States have published the research work: Editorial: Editors u2019 showcase: hepatology, in the Journal: (JOURNAL) of 21/04/2023
- what: The study evaluated 61 patients who underwent the treatment at the Second Affiliated Hospital of Nanchang University and found an objective response rate (ORR) of 36.1% (RECIST 1.1)/57.4% (mRECIST) and a disease control rate (DCR) of 82.0%.
SUMMARY
Frontiers and the editorial team of Liver section of their Gastroenterology journal needs to be congratulated for putting together . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.